Read the description of severe symptoms in section 4 of this leaflet“Contact your doctor immediately if you experience any of the following symptoms after taking this medicine as they may be serious”.
Muscle weakness, sensitivity, or pain, especially if you feel unwell or have a fever, could be due to an abnormal breakdown of muscle fibers that may lead to kidney problems and put your life at risk. You may also experience urine discoloration, and changes in blood test results (significant increase in creatine phosphokinase in blood). If you experience any of these signs or symptoms, please contact your doctor immediately.
Use of Neurontin with other medicines
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medicine. In particular, inform your doctor (or pharmacist) if you are taking or have taken recently any medicine for seizures, sleep disorders, depression, anxiety, or any other neurological or psychiatric problem.
Medicines containing opioids such as morphine
If you are taking any medicine containing opioids (such as morphine), inform your doctor or pharmacist as opioids may increase the effect of Neurontin. Additionally, the combination of Neurontin with opioids may cause drowsiness, sedation, decreased breathing, or death.
Antacids for indigestion
If you take Neurontin at the same time as antacids containing aluminum and magnesium, the absorption of Neurontin in the stomach may be reduced. It is recommended that Neurontin be taken at least two hours after taking an antacid.
Neurontin
- no interaction is expected with other antiepileptic medicines or with the oral contraceptive pill.
- it may interfere with some laboratory tests, so if you need a urine test, inform your doctor or the hospital about what you are taking.
Taking Neurontin with food
Neurontin can be taken with or without food.
Pregnancy, breastfeeding, and fertility
Pregnancy
Neurontin can be used during the first trimester of pregnancy if necessary.
If you are planning to become pregnant or if you become pregnant or think you may be pregnant, consult your doctor immediately.
If you become pregnant and have epilepsy, it is essential not to stop taking your medicine without consulting your doctor first, as this may worsen your condition. Stopping your treatment may put both you and your unborn baby at risk.
In a study reviewing data from women in Nordic countries who took gabapentin in the first 3 months of pregnancy, there was no increased risk of birth defects or problems with brain development (neurodevelopmental disorders). However, babies of women who took gabapentin during pregnancy had a higher risk of low birth weight and premature birth.
Contact your doctor immediately if you become pregnant, think you may be pregnant, or are planning to become pregnant while taking Neurontin.Do not stop taking this medicine abruptly as this may cause an anticipation of seizures, which could have serious consequences for both you and your baby.
Breastfeeding
Gabapentin, the active ingredient in Neurontin, passes into breast milk. It is not recommended to breastfeed while taking Neurontin, as the effect on the baby is unknown.
Fertility
No effects on fertility were observed in animal studies.
Driving and operating machinery
Neurontin may cause dizziness, drowsiness, and fatigue. Do not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know if this medicine affects your ability to perform other tasks.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.Do not take a quantity of medication higher than the prescribed one.
Your doctor will determine what dose is suitable for you.
Epilepsy, the recommended dose is
Adults and adolescents
Take the number of capsules as indicated by your doctor. Normally, your doctor will gradually increase your dose. The initial dose will generally be 300 to 900 mg per day. From there, the dose can be increased as indicated by your doctor up to a maximum dose of 3,600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
Children 6 years or older
Your doctor will decide on the dose to be administered to your child based on the child's weight.The treatment will begin with a low initial dose that will be gradually increased over a period of approximately 3 days. The normal dose for controlling epilepsy is 25-35 mg per kg per day. The dose is normally administered by ingestion of the capsules, divided into 3 equal doses per day, normally one in the morning, one at noon, and one at night.
Neurontin is not recommended for use in children under 6 years of age.
Peripheral neuropathic pain, the recommended dose is
Adults
Take the number of capsules as indicated by your doctor. Normally, your doctor will gradually increase your dose. The initial dose will generally be 300 to 900 mg per day. From there, the dose can be increased as indicated by your doctor up to a maximum dose of 3,600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
If you have kidney problems or are being hemodialyzed
Your doctor may prescribe another dosing regimen and/or different doses if you have kidney problems or are being hemodialyzed.
If you are an elderly patient (over 65 years of age)
You should take the normal dose of Neurontin, except if you have kidney problems.
Your doctor may prescribe another dosing regimen or different doses if you have kidney problems.
If you consider that the effect of Neurontin is too strong or too weak, inform your doctor or pharmacist as soon as possible.
Method of administration
Neurontin is administered orally.Swallow the capsules with a sufficient amount of water. The capsule can be divided into two equal halves.
Continue taking Neurontin until your doctor tells you to stop.
If you take more Neurontin than you should
Doses higher than recommended may cause an increase in adverse effects, including loss of consciousness, dizziness, double vision, slurred speech, numbness, and diarrhea. In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested, or go to the emergency unit of the nearest hospital if you take more Neurontin than your doctor prescribed.Bring with you any capsules that you have not taken, along with the packaging and the leaflet so that the hospital can easily identify the medication you have taken.
If you forget to take Neurontin
If you forget to take a dose, take it as soon as you remember, unless it is time for the next dose.Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Neurontin
Do not stop taking Neurontin suddenly. If you want to stop taking Neurontin, talk to your doctor first. Your doctor will indicate how to proceed.If you are going to stop treatment, this should be done gradually over a minimum of one week.You should know that you may experience certain adverse effects, called withdrawal syndrome, after interrupting a short or long-term treatment with Neurontin. These include seizures, anxiety, difficulty sleeping, feeling of discomfort (nausea), pain, sweating, tremors, headache, depression, abnormal sensation, dizziness, and general feeling of discomfort. These effects usually occur within the first 48 hours after stopping treatment with Neurontin. If you experience this withdrawal syndrome, contact your doctor.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medicationcan cause side effects, although not everyone will experience them.
Contact your doctor immediately if you experience any of the following symptoms after taking this medication, as they may be serious:
Contact your doctor immediately if you have any of the following symptoms:
• skin rash and redness and/or hair loss
• hives
• fever
• persistent swelling of the glands
• swelling of the lips, face, and tongue
• yellowing of the skin or white of the eyes
• unusual bleeding or bruising
• severe fatigue or weakness
• unexpected muscle pain
• frequent infections
These symptoms may be the first signs of a severe reaction. You should have a doctor examine you to decide if you should continue taking Neurontin.
Other side effects include:
Very common: (may affect more than 1 in 10 people)
Common: (may affect up to 1 in 10 people)
Additionally, in clinical trials in children, aggressive behavior and spasmodic movements were reported as common side effects..
Rare: (may affect up to 1 in 1000 people)
After the commercialization of Neurontin, the following side effects have been reported:
Reporting side effects
If you experience any type of side effect, consultyour doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keepthis medicationout of sightand out of reachof children.
Do not usethis medicationafter the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Medications should not be disposed of through drains or in the trash. Dispose of containers and medications you no longer need at the SIGRE collection pointat the pharmacy.Please ask your pharmacist how to dispose of containers and medicationsyou no longer need.This will help protect the environment.
The active ingredient is gabapentin. Each film-coated tablet contains 800 mg of gabapentin.
The other components of Neurontin 800 mg film-coated tablets are:poloxamer 407 (ethylene oxide and propylene oxide), copovidone, cornstarch and magnesium stearate.
Coating: Opadry White YS-1-18111 (hydroxypropylcellulose, talc).
Polishing agent: candelilla wax.
Appearance of the product and contents of the pack
The 800 mg tablets are white, film-coated, elliptical tablets with a notch on both sides and, which bear the imprint “NT” on one half and “26” on the other.
They are available in PVC/PE/PVDC/aluminium or PVC/PVDC/aluminium blisters included in packs of 20, 30, 45, 50, 60, 84, 90, 100, 200 and 500 tablets.
Only some pack sizes may be marketed.
Marketing authorisation holder and manufacturer responsible
Marketing authorisation holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer responsible
Pfizer Manufacturing Deutschland GmbH
Mooswaldallee 1
79108 Freiburg im Breisgau
Germany
or
MEDIS INTERNATIONAL a.s., production plant Bolatice
Prumyslová 961/16
747 23 Bolatice
Czech Republic
You can request more information about this medicine by contacting the local representative of the marketing authorisation holder
Viatris Pharmaceuticals, S.L.U.
Calle General Aranaz, 86
28027 Madrid
Spain
This medicine is authorised in the following member states of the European Economic Area and in the United Kingdom (Northern Ireland)with the following name: Neurontin
Member state name | Medicine name |
Austria | Neurontin 600 mg Filmtabletten Neurontin 800 mg Filmtabletten |
Belgium/Luxembourg | Neurontin 600 mg comprimés pelliculés/filmomhulde tabletten/Filmtabletten, Neurontin 800 mg comprimés pelliculés/filmomhulde tabletten/Filmtabletten |
Czech Republic | Neurontin 600mg Neurontin 800mg |
Denmark | Neurontin |
Finland | Neurontin 600 mg tabletti, kalvopäällysteinen Neurontin 800 mg tabletti, kalvopäällysteinen |
France | Neurontin 600 mg comprimé pelliculé, Neurontin 800 mg comprimé pelliculé |
Germany | Neurontin 600 mg Filmtabletten Neurontin 800 mg Filmtabletten |
Greece | Neurontin 600 mg film-coated tablets, Neurontin 800 mg film-coated tablets |
Iceland | Neurontin |
Ireland | Neurontin 600 mg film-coated tabletsNeurontin 800 mg film-coated tablets |
Latvia | Neurontin 600mgapvalkotas tabletes Neurontin 800mg apvalkotas tabletes |
Netherlands | Neurontin 600, filmomhulde tabletten 600 mg Neurontin 800, filmomhulde tabletten 800 mg |
Norway | Neurontin 600 mg tabletter, filmdrasjerte Neurontin 800 mg tabletter, filmdrasjerte |
Poland | Neurontin 600 Neurontin 800 |
Portugal | Neurontin |
Slovenia | Neurontin 600 mg filmsko obložene tablete Neurontin 800 mg filmsko obložene tablete |
Spain | Neurontin 600 mg comprimidos recubiertos con película Neurontin 800mg comprimidos recubiertoscon película |
Sweden | Neurontin 600 mg filmdragerade tabletter Neurontin 800 mg filmdragerade tabletter |
United Kingdom (Northern Ireland) | Neurontin 600 mg Film-coated Tablets Neurontin 800 mg Film-coated Tablets |
Last review date of this leaflet: July 2023
Detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.